Abstract
Central nervous system (CNS) infection is a global health problem with high rate of mortality and associated morbidities. Viruses, bacteria, fungi, and protozoa parasites are the main cause of CNS infection. Various medications are currently used for treatment of brain infections, but most of them do not have enough efficiency because the majority of conventional drugs cannot pass the blood–brain barrier (BBB) to combat the pathogens. Nanotechnology has provided promising approaches to solve this issue, since nanoparticles (NPs) can facilitate the drugs entrance through the BBB. Herein, we systematically reviewed all available literature to provide evidences for practicality of NPs in treatment of CNS infection. A systematic literature search was performed on January 29, 2021, in Web of Science, PubMed, Scopus, Science Direct, Embase, Ovid, and Google Scholar using “CNS infections” and “NPs/nanoformulation” including all their equivalent terms as keyword. Due to lack of human studies, no strict inclusion criteria were defined, and all relevant documents were included. After several steps of article selection, a total of 29 documents were collected and used for data synthesis. The results showed that drug-loaded NPs is fairly safe and can be a promising approach in developing anti-infective agents for treatment of CNS infection, since nanoformulated drugs could act up to tenfold more efficient that drug alone. Findings of this review indicate the importance of NPs and nanoformulation of drugs to enhance the efficiency of treatment and warrant the safety of treatment in human studies; however, clinical trials are required to confirm such efficiency and safety in clinical practice.
Similar content being viewed by others
References
Aghazadeh H, Memariani H, Ranjbar R, Pooshang Bagheri K (2019) The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli. Chem Biol Drug Des 93:75–83
Allahyari F, Hosseinzadeh R, Nejad JH, Heiat M, Ranjbar R (2021) A case report of simultaneous autoimmune and COVID-19 encephalitis. J Neurovirol. Apr 26:1–3. https://doi.org/10.1007/s13365-021-00978-w. Epub ahead of print. PMID: 33904138; PMCID: PMC8075017
Alhazmi A, Lazrek M, Alidjinou EK, Engelmann I, Schuffenecker I, Dubos F, Hober D (2020) Repeated viral meningitis in a newborn. J Neurovirol 26:449–451
Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in Neurodegenerative Diseases Immunology 129:154–169
Anwar A, Masri A, Rao K, Rajendran K, Khan NA, Shah MR, Siddiqui R (2019a) Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids. Sci Rep 9:3122
Anwar A, Mungroo MR, Sullivan WJ Jr, Khan NA, Siddiqui R (2019b) Repositioning of Guanabenz in conjugation with gold and silver nanoparticles against pathogenic Amoebae Acanthamoeba castellanii and Naegleria fowleri. ACS Infect Dis 5:2039–2046
Asoodeh A, Sepahi S, Ghorani-Azam A (2014) Purification and Modeling amphipathic alpha helical antimicrobial peptides from skin secretions of Euphlyctis cyanophlyctis. Chem Biol Drug Des 83:411–417
Baldissera MD, Souza CF, Boligon AA, Grando TH, MF DES, AS DAS, Stefani LM, Baldisserotto B, Monteiro SG (2017) Solving the challenge of the blood-brain barrier to treat infections caused by Trypanosoma evansi: evaluation of nerolidol-loaded nanospheres in mice. Parasitology 144:1543–1550
Cui Y, Zhao Y, Tian Y, Zhang W, Lu X, Jiang X (2012) The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. Biomaterials 33:2327–2333
Davis LE (2018) Acute bacterial meningitis. Continuum (Minneap Minn) 24: 1264–1283
Demento SL, Bonafe N, Cui W, Kaech SM, Caplan MJ, Fikrig E, Ledizet M, Fahmy TM (2010) TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J Immunol 185:2989–2997
Dende C, Meena J, Nagarajan P, Nagaraj VA, Panda AK, Padmanaban G (2017) Nanocurcumin is superior to native curcumin in preventing degenerative changes in Experimental Cerebral Malaria. Sci Rep 7:10062
Denora N, Trapani A, Laquintana V, Lopedota A, Trapani G (2009) Recent advances in medicinal chemistry and pharmaceutical technology–strategies for drug delivery to the brain. Curr Top Med Chem 9:182–196
Du W, Li H, Tian B, Sai S, Gao Y, Lan T, Meng Y, Ding C (2019) Development of nose-to-brain delivery of ketoconazole by nanostructured lipid carriers against cryptococcal meningoencephalitis in mice. Colloids Surf B Biointerfaces 183: 110446
Farouk F, Shebl RI (2018) Comparing surface chemical modifications of zinc oxide nanoparticles for modulating their antiviral activity against Herpes Simplex Virus Type-1. Int J Nanopart Nanotechnol 4:1–14
Fischer NO, Infante E, Ishikawa T, Blanchette CD, Bourne N, Hoeprich PD, Mason PW (2010) Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent West Nile encephalitis. Bioconjug Chem 21:1018–1022
Gerson T, Makarov E, Senanayake TH, Gorantla S, Poluektova LY, Vinogradov SV (2014) Nano-NRTIs demonstrate low neurotoxicity and high antiviral activity against HIV infection in the brain. Nanomedicine 10:177–185
Ghafoorianfar S, Ghorani-Azam A, Mohajeri SA, Farzin D (2020) Efficiency of nanoparticles for treatment of ocular infections: Systematic literature review. J Drug Deliv Sci Technol 57: 101765
Ghorani-Azam A, Balali-Mood M, Aryan E, Karimi G, Riahi-Zanjani B (2018) Effect of amino acid substitution on biological activity of cyanophlyctin-β and brevinin-2R. J Mol Struct 1158:14–18
Ghorani-Azam A, Balali-Mood M, Khatami SM, Asoodeh A, Es’haghi Z, Riahi-Zanjani B (2021) Plant extract and herbal products as potential source of sorbent for analytical purpose: an experimental study of morphine and codeine determination using HPLC and LC–MSMS. J Chromatogr Sci 59:482–489
Govindarajan M, Rajeswary M, Veerakumar K, Muthukumaran U, Hoti SL, Benelli G (2016) Green synthesis and characterization of silver nanoparticles fabricated using Anisomeles indica: Mosquitocidal potential against malaria, dengue and Japanese encephalitis vectors. Exp Parasitol 161:40–47
Gurunathan S, Kang MH, Qasim M, Kim JH (2018) Nanoparticle-mediated combination therapy: two-in-one approach for cancer. Int J Mol Sci 19
He B, Ma S, Peng G, He D (2018) TAT-modified self-assembled cationic peptide nanoparticles as an efficient antibacterial agent. Nanomedicine 14:365–372
Heckenberg SG, Brouwer MC, van de Beek D (2014) Bacterial meningitis. Handb Clin Neurol 121:1361–1375
Hong W, Zhang Z, Liu L, Zhao Y, Zhang D, Liu M (2018) Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic((R)) P85 unimers. Drug Deliv 25:1886–1897
Hosseini MJ, Halaji M, Nejad JH, Ranjbar R (2021) Central nervous sys-tem vasculopathy associated with severe acute respiratory syn-drome coronavirus 2 (SARS-CoV-2): a novel case report from Iran. J Neurovirol. Apr 19:1–3. https://doi.org/10.1007/s13365-021-00979-9. Epub ahead of print. PMID: 33876411; PMCID: PMC8054843
Jayant RD, Atluri VSR, Tiwari S, Pilakka-Kanthikeel S, Kaushik A, Yndart A, Nair M (2017) Novel nanoformulation to mitigate co-effects of drugs of abuse and HIV-1 infection: towards the treatment of NeuroAIDS. J Neurovirol 23:603–614
Jayant RD, Tiwari S, Atluri V, Kaushik A, Tomitaka A, Yndart A, Colon-Perez L, Febo M, Nair M (2018) Multifunctional nanotherapeutics for the treatment of neuroAIDS in drug abusers. Sci Rep 8:12991
Kennedy PG, Mogensen TH (2020) Determinants of neurological syndromes caused by varicella zoster virus (VZV). J Neurovirol 26:482–495
Khomarlou N, Aberoomand-Azar P, Lashgari AP, Tebyanian H, Hakakian A, Ranjbar R, Ayatollahi SA (2018) Essential oil composition and in vitro antibacterial activity of Chenopodium album subsp. striatum. Acta Biol Hung 69:144–155
Koyuncu OO, Enquist LW, EA E (2020) Invasion of the nervous system. Curr Issues Mol Biol 41:1–62
LaBauve AE, Rinker TE, Noureddine A, Serda RE, Howe JY, Sherman MB, Rasley A, Brinker CJ, Sasaki DY, Negrete OA (2018) Lipid-coated mesoporous silica nanoparticles for the delivery of the ML336 antiviral to inhibit encephalitic alphavirus infection. Sci Rep 8:13990
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34
Marcianes P, Negro S, Garcia-Garcia L, Montejo C, Barcia E, Fernandez-Carballido A (2017) Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis. Int J Nanomedicine 12:1959–1968
Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K (2017) Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. Chem Biol Drug Des 89:327–338
Mirzaie A, Halaji M, Dehkordi FS, Ranjbar R, Noorbazargan H (2020a) A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19). Complemen-tary Therapies in Clinical Practice 40:101214
Mirzaei R, Karampoor S, Sholeh M, Moradi P, Ranjbar R, Ghasemi F (2020b) A contemporary review on pathogenesis and immunity of COVID-19 infection. Mol Biol Rep 47(7):5365–5376
Mohammadpour S, Torshizi Esfahani A, Halaji M, Lak M, Ranjbar R (2021) An updated review of the association of host genetic fac-tors with susceptibility and resistance to COVID-19 J Cell Physiol 236:49–54
Mohseni S, Aghayan M, Ghorani-Azam A, Behdani M, Asoodeh A (2014) Evaluation of antibacterial properties of Barium Zirconate Titanate (BZT) nanoparticle. Braz J Microbiol 45:1393–1399
Okamoto S, Yoshii H, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y (2008) Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus. Vaccine 26:589–594
Okamoto S, Yoshii H, Matsuura M, Kojima A, Ishikawa T, Akagi T, Akashi M, Takahashi M, Yamanishi K, Mori Y (2012) Poly-gamma-glutamic acid nanoparticles and aluminum adjuvant used as an adjuvant with a single dose of Japanese encephalitis virus-like particles provide effective protection from Japanese encephalitis virus. Clin Vaccine Immunol 19:17–22
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S, Shin HS (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology 16:71
Pokorn M (2004) Pathogenesis and Classification of Central Nervous System Infection. EJIFCC 15:68–71
Prabhu P, Suryavanshi S, Pathak S, Patra A, Sharma S, Patravale V (2016) Nanostructured lipid carriers of artemether-lumefantrine combination for intravenous therapy of cerebral malaria. Int J Pharm 513:504–517
Rai A, Prabhune A, Perry CC (2010) Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem 20:6789
Rai M, Yadav A, Gade A (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27:76–83
Rekha R, Vaseeharan B, Vijayakumar S, Abinaya M, Govindarajan M, Alharbi NS, Kadaikunnan S, Khaled JM, Al-Anbr MN (2019) Crustin-capped selenium nanowires against microbial pathogens and Japanese encephalitis mosquito vectors—insights on their toxicity and internalization. J Trace Elem Med Biol 51:191–203
Riahi-Zanjani B, Balali-Mood M, Asoodeh A, Es’haghi Z, Ghorani-Azam A (2019a) Potential application of amino acids in analytical toxicology. Talanta 197:168–174
Riahi-Zanjani B, Balali-Mood M, Es’haghi Z, Asoodeh A, Ghorani-Azam A (2019b) Molecular modeling and experimental study of a new peptide-based microextraction fiber for preconcentrating morphine in urine samples. J Mol Model 25:54
Riahi-Zanjani B, Balali-Mood M, Es’haghi Z, Asoodeh A, Ghorani-Azam A (2019c) Preconcentration of morphine in urine sample using a green and solvent-free microextraction method. Green Processing and Synthesis 8:542–550
Ritskes-Hoitinga M, Leenaars M, Avey M, Rovers M, Scholten R (2014) Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine. Cochrane Database Syst Rev: ED000078
Rodriguez-Izquierdo I, Mj S, Fj M, Mj B, Ma MF (2020) Gold nanoparticles crossing blood-brain barrier prevent HSV-1 infection and reduce herpes associated amyloid-betasecretion. J Clin Med 9
Rodriguez M, Kaushik A, Lapierre J, Dever SM, El-Hage N, Nair M (2017) Electro-magnetic nano-particle bound Beclin1 siRNA crosses the blood-brain barrier to attenuate the inflammatory effects of HIV-1 infection in Vitro. J Neuroimmune Pharmacol 12:120–132
Salehpour M, Tayyebi Meibodi N, Teimourpour R, Ghorani-Azam A, Sepahi S, Rostami S, Meshkat Z (2015) Frequency of human papillomavirus genotypes 6, 11, 16, 18 And 31 in paraffin-embedded tissue samples of invasive breast carcinoma, North- East of Iran. Iran J Pathol 10:192–198
Sellner J, Tauber MG, Leib SL (2010) Pathogenesis and pathophysiology of bacterial CNS infections. Handb Clin Neurol 96:1–16
Shao K, Huang R, Li J, Han L, Ye L, Lou J, Jiang C (2010) Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain. J Control Release 147:118–126
Singh R, Lillard JW Jr (2009) Nanoparticle-based targeted drug delivery. Exp Mol Pathol 86:215–223
Tang X, Liang Y, Zhu Y, Xie C, Yao A, Chen L, Jiang Q, Liu T, Wang X, Qian Y, Wei J, Ni W, Dai J, Jiang Z, Hou W (2015) Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity. Int J Nanomedicine 10:6227–6241
Teulon JM, Godon C, Chantalat L, Moriscot C, Cambedouzou J, Odorico M, Ravaux J, Podor R, Gerdil A, Habert A, Herlin-Boime N, Chen SW, Pellequer JL (2018) On the operational aspects of measuring nanoparticle sizes. Nanomaterials (Basel) 9
Tseng YY, Wang YC, Su CH, Liu SJ (2015) Biodegradable vancomycin-eluting poly[(d, l)-lactide-co-glycolide] nanofibres for the treatment of postoperative central nervous system infection. Sci Rep 5:7849
Ubale RV, Gala RP, Zughaier SM, D’Souza MJ (2014) Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles. AAPS J 16:986–993
van Luijk J, Bakker B, Rovers MM, Ritskes-Hoitinga M, de Vries RB, Leenaars M (2014) Systematic reviews of animal studies; missing link in translational research? PLoS One 9: e89981
Vanka R, Kuppusamy G, Praveen Kumar S, Baruah UK, Karri V, Pandey V, Babu PP (2018) Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers. J Microencapsul 35:121–136
Waknine-Grinberg JH, Even-Chen S, Avichzer J, Turjeman K, Bentura-Marciano A, Haynes RK, Weiss L, Allon N, Ovadia H, Golenser J, Barenholz Y (2013) Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria. PLoS One 8: e72722
Wang H, Xu K, Liu L, Tan JP, Chen Y, Li Y, Fan W, Wei Z, Sheng J, Yang YY, Li L (2010) The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis. Biomaterials 31:2874–2881
Xu K, Wang H, Liu L, Xu W, Sheng J, Fan W, Yang YY, Li L (2011a) Efficacy of CG(3)R(6)TAT nanoparticles self-assembled from a novel antimicrobial peptide for the treatment of Candida albicans meningitis in rabbits. Chemotherapy 57:417–425
Xu N, Gu J, Zhu Y, Wen H, Ren Q, Chen J (2011b) Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int J Nanomedicine 6:905–913
Zare-Zardini H, Ferdowsian F, Soltaninejad H, Ghorani Azam A, Soleymani S, Zare-Shehneh M, Mofidi M, Rafati R, Ebrahimi L (2015) Application of nanotechnology in biomedicine: a major focus on cancer therapy. J Nano Res 35:55–66
Zhai Y, Zhou Y, Li X, Feng G (2015) Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor. Mol Med Rep 12:199–209
Zhang SS, Asghar S, Ye JX, Lin L, Ping QN, Chen ZP, Shao F, Xiao YY (2020) A combination of receptor mediated transcytosis and photothermal effect promotes BBB permeability and the treatment of meningitis using itraconazole. Nanoscale 12:23709–23720
Zhao S, Duan H, Yang Y, Yan X, Fan K (2019) Fenozyme protects the integrity of the blood-brain barrier against experimental cerebral malaria. Nano Lett 19:8887–8895
Zhu S, Huang AG, Luo F, Li J, Zhu L, Zhao L, Zhu B, Ling F, Wang GX (2019) Application of virus targeting nanocarrier drug delivery system in virus-induced central nervous system disease treatment. ACS Appl Mater Interfaces 11:19006–19016
Acknowledgements
The authors would like to thank the Clinical Research Development Unit of Baqiyatallah Hospital, Tehran, Iran, for guidance and advice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Consent for publication
The authors agree to publish this manuscript in the journal of neurovirology.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lashkari, A., Ranjbar, R. Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature. J. Neurovirol. 27, 542–549 (2021). https://doi.org/10.1007/s13365-021-00994-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-021-00994-w